Related Experiment Videos
Dysregulation of immune response following neurosurgical operations
A Sablotzki1, H Ebel, J Mühling
1Department of Anaesthesiology and Intensive Care Medicine, Justus-Liebig-University, Giessen, Germany.
Insights
Glioblastoma patients exhibit immune system dysregulation, with higher levels of IL-10 and TGF-beta, and lower NK and T-cells compared to aneurysm patients. This suggests immune impairment may be linked to these specific cytokines.
Area of Science:
- Neurosurgery
- Immunology
- Oncology
Background:
- Postoperative infections are a significant risk in neurosurgery.
- Central nervous system surgery and brain tumors can impair immune function.
- Investigating immune differences in glioblastoma vs. aneurysm patients is crucial.
Purpose of the Study:
- To compare cell-mediated immunity in glioblastoma and intracerebral aneurysm patients.
- To identify specific immune markers differentiating these patient groups.
- To understand the impact of craniotomy on immune status.
Main Methods:
- Measured cytokine concentrations (IL-6, IL-10, TGF-beta1) in 16 patients (8 glioblastoma, 8 aneurysm).
- Analyzed lymphocyte subsets (CD3+, CD3+HLA-DR+, CD4+, CD8+, CD19+, CD16+56+) pre-, intra-, and post-operatively.
- Correlated immune changes with underlying neurosurgical conditions.
Main Results:
- Aneurysm patients had higher pre- and intraoperative IL-6 levels.
- Glioma patients showed significantly elevated IL-10 and TGF-beta1 plasma concentrations.
- Glioma patients had a lower percentage of Natural Killer (NK) cells and activated T-cells.
Conclusions:
- Glioma patients demonstrate significant immune response dysregulation.
- Elevated plasma levels of IL-10 and TGF-beta1 may induce immunosuppression in glioma patients.
- These findings highlight potential therapeutic targets for managing immune function in neuro-oncology.
Background:
Postoperative infections are common and potentially fatal complications in neurosurgical intensive care medicine. An impairment of immune function has been described after central nervous system surgery and in patients harboring malignant brain tumors. The aim of our study was to investigate whether differences in cell-mediated immunity can be found in patients undergoing craniotomy for surgery of glioblastoma or clipping of an intracerebral aneurysm.
Methods:
In order to determine the influence of the underlying disease on the immune system, we measured changes in cytokine concentrations (IL-6, IL-10, TGF-beta1) and lymphocyte-subsets (CD3+, CD3+HLA-DR+, CD4+, CD8+, CD19+, and CD16+56+) in 8 patients with glioblastoma and in 8 patients with an intracerebral aneurysm before, during and after the neurosurgical procedure.
Results:
In the comparison of glioblastoma and aneurysm patients, we could show that IL-6 plasma levels were pre- and intraoperatively higher in the aneurysm-group (P<0.05), and the plasma concentrations of IL-10 and TGF-beta were significantly elevated in the glioma-group. The lymphocyte-subsets showed a significantly lower percentage of NK-cells and activated T-cells in the glioma-group.
Conclusion:
Our results document a significant dysregulation of immune response in glioma patients. This may be induced by elevated plasma concentrations of immunoinhibiting cytokines IL-10 and transforming growth factor-beta 1.